Find trials
Search tips

A Study Of Virtual Reality Vs Sham VR On Fibromyalgia

Overview

About this study

The purpose of this study is to understand the therapeutic impact of VR on Fibromyalgia symptoms and potentially increase the scope of treatment options for patients suffering from Fibromyalgia.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults aged >18 years old

  • Diagnosis of fibromyalgia based on ACR 2016 criteria

  • Stable on current medications and non-pharmacologic treatments for ≥4 weeks

  • Ability and willingness to use a Meta Quest 3 VR headset

  • Fluent in English

  • Provide informed consent

 

Exclusion Criteria:

  • History of seizures or conditions contraindicating VR use

  • Severe psychiatric illness (e.g., psychosis)

  • Cognitive impairment interfering with study participation

  • Participation in other interventional trials

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 

Eligibility last updated 06/17/2025. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Anushka Irani, B.M., B.Ch., Ph.D.

Contact us for the latest status

Contact information:

Wendi Lehman

(904) 953-8742

lehman.wendi@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20598485

Mayo Clinic Footer